These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18446294)

  • 21. Conformational propagation with prion-like characteristics in a simple model of protein folding.
    Harrison PM; Chan HS; Prusiner SB; Cohen FE
    Protein Sci; 2001 Apr; 10(4):819-35. PubMed ID: 11274473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core.
    Wasmer C; Lange A; Van Melckebeke H; Siemer AB; Riek R; Meier BH
    Science; 2008 Mar; 319(5869):1523-6. PubMed ID: 18339938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prion versus doppel protein misfolding: new insights from replica-exchange molecular dynamics simulations.
    Baillod P; Garrec J; Tavernelli I; Rothlisberger U
    Biochemistry; 2013 Nov; 52(47):8518-26. PubMed ID: 24143866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simulated pathogenic conformational switch regions matched well with the biochemical findings.
    Liu X; Zhao YP
    J Biomed Inform; 2010 Jun; 43(3):365-75. PubMed ID: 20026248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of protein-folding pathways by reduced-space modeling.
    Kmiecik S; Kolinski A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12330-5. PubMed ID: 17636132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between prion diseases and conformational transition of peptides].
    Yanagawa H; Ogawa Y
    Tanpakushitsu Kakusan Koso; 2001 Aug; 46(11 Suppl):1789-97. PubMed ID: 11579580
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The controversial protein-only hypothesis of prion propagation.
    Soto C; Castilla J
    Nat Med; 2004 Jul; 10 Suppl():S63-7. PubMed ID: 15272271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folding of small proteins by Monte Carlo simulations with chemical shift restraints without the use of molecular fragment replacement or structural homology.
    Robustelli P; Cavalli A; Dobson CM; Vendruscolo M; Salvatella X
    J Phys Chem B; 2009 Jun; 113(22):7890-6. PubMed ID: 19425536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing the denatured state of human prion 121-230.
    Lee CI; Chang NY
    Biophys Chem; 2010 Sep; 151(1-2):86-90. PubMed ID: 20627399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure, dynamics, and stability of assemblies of the human prion fragment SNQNNF.
    De Simone A; Pedone C; Vitagliano L
    Biochem Biophys Res Commun; 2008 Feb; 366(3):800-6. PubMed ID: 18082625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Essential role of hydration in aggregation of misfolded prion proteins: quantification by molecular theory of solvation.
    Yamazaki T; Blinov N; Wishart D; Kovalenko A
    J Toxicol Environ Health A; 2009; 72(17-18):1060-8. PubMed ID: 19697240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein misfolding cyclic amplification for diagnosis and prion propagation studies.
    Castilla J; Saá P; Morales R; Abid K; Maundrell K; Soto C
    Methods Enzymol; 2006; 412():3-21. PubMed ID: 17046648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational preferences of the full chicken prion protein in solution and its differences with respect to mammals.
    Pietropaolo A; Muccioli L; Zannoni C; Rizzarelli E
    Chemphyschem; 2009 Jul; 10(9-10):1500-10. PubMed ID: 19492390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oscillatory molecular driving force for protein folding at high concentration: a molecular simulation.
    Lu D; Liu Z
    J Phys Chem B; 2008 Mar; 112(9):2686-93. PubMed ID: 18266355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unveiling the role of histidine and tyrosine residues on the conformation of the avian prion hexarepeat domain.
    Pietropaolo A; Muccioli L; Zannoni C; La Mendola D; Maccarrone G; Pappalardo G; Rizzarelli E
    J Phys Chem B; 2008 Apr; 112(16):5182-8. PubMed ID: 18386869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models.
    DeMarco ML; Silveira J; Caughey B; Daggett V
    Biochemistry; 2006 Dec; 45(51):15573-82. PubMed ID: 17176078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topology-based potentials and the study of the competition between protein folding and aggregation.
    Prieto L; Rey A
    J Chem Phys; 2009 Mar; 130(11):115101. PubMed ID: 19317567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misfolding of the prion protein: linking biophysical and biological approaches.
    Noinville S; Chich JF; Rezaei H
    Vet Res; 2008; 39(4):48. PubMed ID: 18533092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Amyloidosis, protein conformation dynamics and neurologic diseases].
    Tranchant C; Rodier G; Schmitthaeusler R; Warter JM
    Rev Neurol (Paris); 1996 Mar; 152(3):153-7. PubMed ID: 8761624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.